AstraZeneca Press Office home

AstraZeneca Press Office - Keeping the International Media informed

Welcome to the AstraZeneca Press Office. This website is for an international audience of journalists with an interest in AstraZeneca News. If you are in the US you should visit AstraZeneca US.
Product licenses differ between countries. Please consult your local prescribing information. For other countries, check here for a list of country-specific AstraZeneca websites

Latest Press Releases

6 May 2008: THE AMERICAN PSYCHIATRIC ASSOCIATION’S AWARDS FOR YOUNG SCIENTISTS ENCOURAGE RESEARCH EXPERTISE IN CHINA, Audience: Medical
6 May 2008: New data on SEROQUEL XR™ in treatment of both major depressive disorder and generalized anxiety disorder presented at APA Annual meeting, Audience: Medical
11 April 2008: AstraZeneca announces first presentation of pivotal SEROQUEL XR™ bipolar studies, Audience: Medical
27 February 2008: AstraZeneca Provides Update On Cediranib (RECENTINTM, AZD2171) Clinical Development Programme, Audience: Medical
15 January 2008: FIRST HEAD TO HEAD STUDY COMPARING CRESTOR™ AND LIPITOR® EFFECTS ON THE TREATMENT OF ATHEROSCLEROSIS, Audience: Medical
18 December 2007: NEW DATA CONFIRM BENEFIT OF EXTENDED ADJUVANT TREATMENT WITH Arimidex™ (ANASTROZOLE), Audience: Medical
14 December 2007: NEW RESULTS FROM ONE OF THE WORLD’S LARGEST BREAST CANCER TRIALS HERALD HOPE FOR THOUSANDS OF WOMEN, Audience: Consumer
To read more Business, Medical and Consumer press releases please Sign in on the right or Register for access

AstraZeneca websites

Sign in

Regional media links

Anastrozole Story

Anastrozole Story

Click here

CAB Report

CAB Report

Click here for more information

© AstraZeneca 2002, 2004